MedDataX Logo

Fetal Growth Pattern in Short Stature Women

NCT ID: NCT04213443

Last Updated: 2021-03-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-31

Study Completion Date

2021-03-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Women of short stature tend to be classified regarding fetal growth by the same criteria as women of normal and tall stature. The objective of the following study is to evaluate fetal growth patterns parallel to women's height and try to make conclusions regarding possible definitions of subjective Intra-uterine growth restriction.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

NCT01734447

Foetal Growth Problem Small for Gestational Age
COMPLETED PHASE4

Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

NCT00458263

Idiopathic Short Stature
COMPLETED PHASE4

Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age

NCT00174460

Growth Hormone Therapy Infant, Very Low Birth Weight
COMPLETED PHASE2

Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age

NCT01897753

Small For Gestational Age (SGA)
COMPLETED

Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy

NCT00625872

Growth Hormone Therapy Infant, Small for Gestational Age
TERMINATED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based on a patient registry, women of short stature tend to be classified regarding fetal growth by the same criteria as women of normal and tall stature. The objective of the following study is to evaluate fetal growth patterns parallel to women's height and try to make conclusions regarding possible definitions of subjective Intra-uterine growth restriction.

Informed consent is not required due to the retrospective nature of the study. Patient information including medical, obstetric and general background will be collected.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intrauterine Growth Restriction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women of short stature

Women that are under 1.6 meters.

Analysis of a patient registry

Intervention Type OTHER

Analysis of a patient registry.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Analysis of a patient registry

Analysis of a patient registry.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women under 1.6 meters of height.
* Singleton pregnancy.
* Low risk pregnancy.
* Accurate dating.

Exclusion Criteria

* Women over 1.6 meters of height.
* Multiple pregnancy.
* High risk pregnancy.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rambam Health Care Campus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ROY LAUTERBACH MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Roy Lauterbach, MD

Role: PRINCIPAL_INVESTIGATOR

Rambam healthcare campus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rambam health care campus

Haifa, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0275-19-RMB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
NCT00174421 COMPLETED PHASE3
Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight
NCT00120497 UNKNOWN
Growth and Asymmetric diMethylArginine
NCT03422081 COMPLETED
Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction
NCT00519844 COMPLETED PHASE4
Molecular Basis of the Growth Axis in Short Stature
NCT00453245 COMPLETED
The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature
NCT01970800 WITHDRAWN NA
Comparison of Follow-up Protocols in Terms of Fetal, Neonatal and Maternal Results in Intrauterine Growth Retardation
NCT04141189 UNKNOWN NA
Follow-up to Adult Height of a Cohort of Subjects Born Small for the Gestational Age and Treated With Growth Hormone
NCT01196156 COMPLETED
Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation
NCT01697644 COMPLETED PHASE4
Use of Customized GROW Charts for Detection of SGA in Low Risk Woman.
NCT04764461 UNKNOWN NA
Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height
NCT00396474 WITHDRAWN
Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)
NCT01438801 WITHDRAWN PHASE4
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 TERMINATED
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605 COMPLETED PHASE3
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
NCT00174408 COMPLETED PHASE3
Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.
NCT03324139 COMPLETED PHASE3
Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age
NCT00557336 COMPLETED PHASE3
A Study to Assess Growth in Children With Idiopathic Short Stature
NCT06309979 RECRUITING
Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature
NCT00121875 TERMINATED
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 COMPLETED PHASE2
Growth Response in Girls With Turner Syndrome
NCT01734486 COMPLETED PHASE4
Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)
NCT01859949 COMPLETED PHASE4
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
NCT04798690 RECRUITING
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
NCT01604395 RECRUITING
Long Term Use of Somatropin in Patients Small for Gestational Age
NCT00793325 COMPLETED